These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 1324797

  • 1. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
    Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR.
    Cancer Res; 1992 Sep 01; 52(17):4832-6. PubMed ID: 1324797
    [Abstract] [Full Text] [Related]

  • 2. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
    Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Vokes EE, Weichselbaum RR.
    Clin Cancer Res; 1996 Apr 01; 2(4):755-62. PubMed ID: 9816227
    [Abstract] [Full Text] [Related]

  • 3. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T.
    Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506
    [Abstract] [Full Text] [Related]

  • 4. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Sisk EA, Soltys SG, Zhu S, Fisher SG, Carey TE, Bradford CR.
    Head Neck; 2002 Sep 01; 24(9):841-9. PubMed ID: 12211048
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes.
    Adams V, Schmid S, Zariwala M, Schmid M, Kleihues P, Briner J, Schäfer R.
    Anticancer Res; 1999 Sep 01; 19(1A):1-6. PubMed ID: 10226517
    [Abstract] [Full Text] [Related]

  • 6. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Goepfert H, Hong WK, Roth JA.
    Cancer Res; 1993 Apr 01; 53(7):1676-83. PubMed ID: 8453641
    [Abstract] [Full Text] [Related]

  • 7. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, Shanmugam G.
    Gynecol Oncol; 1998 Jun 01; 69(3):205-9. PubMed ID: 9648588
    [Abstract] [Full Text] [Related]

  • 8. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 9. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW, Mok CH, Chung G, Huang DP, Wong F, Chan M, Lee JC, Tsao SW.
    Anticancer Res; 1992 Jan 15; 12(6B):1989-94. PubMed ID: 1363512
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer.
    Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J.
    Prostate; 1996 May 15; 28(5):318-24. PubMed ID: 8610059
    [Abstract] [Full Text] [Related]

  • 13. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.
    Clin Cancer Res; 2004 Oct 15; 10(20):6929-37. PubMed ID: 15501971
    [Abstract] [Full Text] [Related]

  • 14. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas.
    Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, Filho JF, Fukuyama EE, Cordeiro JA, Cury PM, Maniglia JV, Villa LL, Tajara EH, Rahal P.
    Cancer Genet Cytogenet; 2004 Apr 01; 150(1):44-9. PubMed ID: 15041222
    [Abstract] [Full Text] [Related]

  • 15. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF, Weissler MC, Pei H, Conway K.
    Cancer Epidemiol Biomarkers Prev; 1997 Jul 01; 6(7):499-504. PubMed ID: 9232336
    [Abstract] [Full Text] [Related]

  • 16. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, Sanghavi V, Mehta AR.
    Oral Oncol; 1999 May 01; 35(3):242-50. PubMed ID: 10621843
    [Abstract] [Full Text] [Related]

  • 17. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
    Rugge M, Bovo D, Busatto G, Parenti AR, Fawzy S, Guido M, Ancona E, Ninfo V, Ruol A, Shiao YH.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 01; 6(3):171-6. PubMed ID: 9138659
    [Abstract] [Full Text] [Related]

  • 18. Frequent p53 mutations in head and neck cancer.
    Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G.
    Cancer Res; 1992 Nov 01; 52(21):5997-6000. PubMed ID: 1394225
    [Abstract] [Full Text] [Related]

  • 19. Carcinoma of the vulva: HPV and p53 mutations.
    Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP.
    Oncogene; 1994 Jun 01; 9(6):1655-9. PubMed ID: 8183560
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
    Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, Notani K, Fukuda H.
    Oncogene; 1996 Apr 18; 12(8):1663-8. PubMed ID: 8622886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.